Omeros (OMER) EBT Margin (2010 - 2026)
Omeros recorded quarterly EBT Margin of 518.61% in Q1 2026, up 785.39% quarter-over-quarter from 75.67% in Q3 2021.
Omeros' EBT Margin history runs 13 years deep, the most recent figure standing at 518.61% for Q1 2026.
- In Q1 2026, EBT Margin changed N/A year-over-year to 518.61%; the TTM figure through Mar 2026 stood at 42.1% (up 17577.0% YoY), while the FY2020 annual figure was 266.06%, down 11657.0% from the prior year.
- EBT Margin came in at 518.61% for Q1 2026 at Omeros, up from 75.67% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 518.61% in Q1 2026 to a low of 518.61% in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | 518.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 518.61% |
| Sep 30, 2021 | -75.67% |
| Jun 30, 2021 | -175.28% |
| Mar 31, 2021 | -238.29% |
| Dec 31, 2020 | -825.31% |
| Sep 30, 2020 | -177.36% |
| Jun 30, 2020 | -248.77% |
| Mar 31, 2020 | -125.67% |
| Dec 31, 2019 | -334.80% |
| Sep 30, 2019 | -55.14% |
| Jun 30, 2019 | -55.58% |
| Mar 31, 2019 | -114.05% |
| Dec 31, 2018 | -107.29% |
| Sep 30, 2018 | -869.01% |
| Jun 30, 2018 | -2,072.08% |
| Mar 31, 2018 | -1,921.54% |
| Dec 31, 2017 | -123.44% |
| Sep 30, 2017 | -36.43% |
| Jun 30, 2017 | -85.49% |
| Mar 31, 2017 | -125.54% |
| Dec 31, 2016 | -110.88% |
| Sep 30, 2016 | -125.55% |
| Jun 30, 2016 | -127.81% |
| Mar 31, 2016 | -280.73% |
| Dec 31, 2015 | -282.37% |
| Sep 30, 2015 | -618.96% |
| Jun 30, 2015 | -530.40% |
| Mar 31, 2015 | -4,867.78% |
| Dec 31, 2014 | -11,719.44% |
| Sep 30, 2014 | -8,445.33% |
| Jun 30, 2014 | -40,335.56% |
| Mar 31, 2014 | -16,354.00% |
| Dec 31, 2013 | -8,239.05% |
| Sep 30, 2013 | -7,155.10% |
| Jun 30, 2013 | -9,819.29% |
| Mar 31, 2013 | -968.13% |
| Dec 31, 2012 | -498.67% |
| Sep 30, 2012 | -948.13% |
| Jun 30, 2012 | -569.53% |
| Mar 31, 2012 | -571.79% |
| Dec 31, 2011 | -907.44% |
| Sep 30, 2011 | -677.10% |
| Jun 30, 2011 | -472.90% |
| Mar 31, 2011 | -542.86% |
| Dec 31, 2010 | -906.56% |
| Sep 30, 2010 | -3,048.82% |
| Jun 30, 2010 | -1,614.08% |